<DOC>
	<DOCNO>NCT01202123</DOCNO>
	<brief_summary>The purpose study evaluate safety efficacy highly purify ( HP ) menotrophine Korean woman .</brief_summary>
	<brief_title>Post Marketing Surveillance MENOPUR</brief_title>
	<detailed_description />
	<mesh_term>Infertility</mesh_term>
	<mesh_term>Menotropins</mesh_term>
	<criteria>Anovulation woman ( WHO group II ) Controlled ovarian hyperstimulation case ART Hypersensitivity MENOPUR Pregnancy , lactation contraindication pregnancy Ovarian cyst relate polycystic ovarian syndrome Abnormal uterine bleed Tumors uterus , ovary breast Ovarian hyperstimulation syndrome Thromboembolism history Infertile due reason anovulation High FSH level indication primary ovarian failure</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2014</verification_date>
</DOC>